ClinicalTrials.gg
CompletedNCT07893613Updated Oct 26, 2026

Effects of Chronic Exercise on Hormonal and Mineral Biomarkers in Male University Students

An interventional study of High-intensity interval training program in Hormonal Response, Mineral Metabolism and Exercise Training, sponsored by High Institute of Sports and Physical Education of Kef. Completed at 1 site in Tunisia. Open to male participants aged 19 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by High Institute of Sports and Physical Education of Kef · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Dec 2025, registered Oct 2026).
Updated Oct 26, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
19 Years to 25 Years
Sex
Male
01

Study summary

The purpose of this study is to investigate the effects of a high-intensity interval training (HIIT) program on hormonal and mineral biomarkers and aerobic fitness in male university students. The study aims to determine whether HIIT improves hormonal biomarkers, including testosterone, cortisol, the testosterone-to-cortisol ratio, and growth hormone (GH), as well as mineral metabolism biomarkers, including parathyroid hormone (PTH), 25-hydroxyvitamin D [25(OH)D], calcium, and phosphate. Participants will be assigned to either a HIIT group or a non-training control group. The HIIT group completed three sessions per week for 9 weeks, alternating 30-second runs at high-intensity and low-intensity. The control group did not participate in the training intervention and maintained its usual daily activities.

Read the detailed description

Chronic exercise, particularly high-intensity interval training (HIIT), is a time-efficient training strategy that may improve cardiorespiratory fitness. However, its effects on resting hormonal biomarkers and mineral metabolism remain insufficiently characterized in male university students. The purpose of this randomized controlled trial was to investigate the effects of a 9-week HIIT program on hormonal biomarkers, mineral metabolism, and aerobic fitness in male university students. The hormonal biomarkers assessed included testosterone, cortisol, the testosterone-to-cortisol ratio, and growth hormone (GH). Mineral metabolism was evaluated by measuring circulating parathyroid hormone (PTH), 25-hydroxyvitamin D [25(OH)D], calcium, and phosphate concentrations. Aerobic fitness was assessed using maximal aerobic speed (MAS) and maximal oxygen uptake (VO2max). Participants were allocated to either an experimental HIIT group or a non-training control group. The HIIT intervention consisted of three sessions per week for 9 weeks. Each session comprised three sets of 6-8 repetitions of 30-second running bouts performed at 100-110% of MAS, interspersed with 30-second active recovery runs at 50% of MAS. The control group did not participate in the HIIT intervention and maintained its usual daily activities. Study outcomes were evaluated before and after the intervention to determine changes in hormonal biomarkers, mineral metabolism, and aerobic fitness.

02

Conditions studied

  • Hormonal Response
  • Mineral Metabolism
  • Exercise Training

Keywords

  • Chronic exercise
  • Testosterone-to-Cortisol Ratio
  • Growth Hormone
  • 25-Hydroxyvitamin D
  • Parathyroid Hormone
  • Mineral Metabolism
  • Maximal Aerobic Speed
  • University Students
03

In context

Lead sponsor

High Institute of Sports and Physical Education of Kef is the lead sponsor of 10 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 19-25 years.
  • Male university students enrolled at the High Institute of Sport and Physical Education of Kef, Tunisia.
  • Provided written .
  • Willing to maintain usual daily routines, habitual physical activity, and dietary habits throughout the 9-week study period.

Exclusion criteria

Exclusion Criteria:

  • Presence of an acute or chronic illness.
  • Any medical condition contraindicating vigorous exercise.
  • Participation in another structured training program within the previous 6 months.
  • Use of medications or dietary supplements within the previous 3 months.
  • Following a restrictive diet within the previous 3 months.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
29 participants (actual)

Study arms

  • Experimental
    Intervention group

    Participants in the intervention group completed a high-intensity interval training (HIIT) program consisting of three sessions per week for 9 weeks. Each session comprised three sets of 6-8 repetitions of 30-second running bouts performed at 100-110% of maximal aerobic speed (MAS), interspersed with 30-second active recovery runs at 50% of MAS.

    Behavioral: High-intensity interval training program

  • No intervention
    Control group

    Participants in the control group maintained their usual daily activities and did not participate in the HIIT intervention throughout the 9-week study period.

Interventions

  • BehavioralHigh-intensity interval training program

    The high-intensity interval training program consisted of three sessions per week for 9 weeks. Each session comprised three sets of 6-8 repetitions of 30-second running bouts performed at 100-110% of maximal aerobic speed (MAS), interspersed with 30-second active recovery runs at 50% of MAS between bouts.

06

What researchers measure

Primary outcomes

  1. Testosterone

    Testosterone concentration, expressed in µg/dL, was measured using enzyme-linked immunosorbent assay (ELISA) kits (Monobind, Inc., Lake Forest, CA).

    Time frame: One day before the start and two days after the completion of the 09 weeks of training program

  2. Cortisol

    Cortisol concentration, expressed in µg/dL, was measured using an automated chemiluminescence immunoassay (DiaSorin Inc., Stillwater, MN).

    Time frame: One day before the start and two days after the completion of the 09 weeks of training program.

  3. Testosterone/cortisol ratio

    Testosterone/cortisol ratio (T/C) was calculated by dividing the testosterone value by the cortisol value for each participant.

    Time frame: One day before the start and two days after the completion of the 09 weeks of training program.

  4. Parathyroid Hormone

    Parathyroid hormone concentration, expressed in pg/mL, was measured using an automated chemiluminescence immunoassay (DiaSorin Inc., Stillwater, MN).

    Time frame: One day before the start and two days after the completion of the 09 weeks of training program.

  5. Growth hormone

    Growth hormone concentration, expressed in mIU/L, was measured using an immunoradiometric assay (IRMA GH; Beckman Coulter).

    Time frame: One day before the start and two days after the completion of the 09 weeks of training program.

  6. 25-hydroxyvitamin D

    25-hydroxyvitamin D \[25(OH)D\] concentration, expressed in ng/mL, was analyzed using an automated chemiluminescence immunoassay (DiaSorin Inc., Stillwater, MN).

    Time frame: One day before the start and two days after the completion of the 09 weeks of training program.

  7. Aerobic capacity

    Aerobic capacity was assessed using the Vameval incremental running test performed to exhaustion (Cazorla, 1999). Maximal aerobic speed (MAS), expressed in km/h, was determined from the highest running speed achieved during the test, and maximal oxygen uptake (VO₂max), expressed in mL·kg-¹·min-¹, was estimated using the Vameval protocol (Cazorla, 1999).

    Time frame: One day before the start and two days after the completion of the 09 weeks of training program.

Secondary outcomes

  1. Calcium

    Calcium concentration, expressed in mg/L, was assessed on Architect C8000 analyzer (Abbott Laboratories, Abbott Park, IL), using the respective reagents kits.

    Time frame: One day before the start and two days after the completion of the 09 weeks of training program.

  2. Phosphorus

    Phosphorus concentration, expressed in mg/L, was assessed on Architect C8000 analyzer (Abbott Laboratories, Abbott Park, IL), using the respective reagents kits.

    Time frame: One day before the start and two days after the completion of the 09 weeks of training program.

07

Study locations

1 site
  • High Institute of Sport and Physical Education of Kef, University of Jendouba Kef, Boulifa, Tunisia, 7100
    El Kef, Boulifa 7100, Tunisia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07893613
Lead sponsor
High Institute of Sports and Physical Education of Kef
Responsible party
Nejmeddine Ouerghi (Principal Investigator, High Institute of Sports and Physical Education of Kef) — Principal investigator
First posted
Oct 26, 2026
Start date
Dec 1, 2025
Primary completion
Feb 18, 2026
Completion
Feb 18, 2026
Last update
Oct 26, 2026

Study contacts

Nejmeddine Ouerghi, Ph.D
principal investigator · Research Unit "Sport Sciences, Health and Movement"(UR22JS01) High Institute of Sport and Physical Education of Kef, University of Jendouba, 7100 Kef, Tunisia.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion